5am Ventures

5AM Ventures is a venture capital firm founded in 2002 and headquartered in San Francisco, California, with an additional office in Boston. The firm specializes in seed- and early-stage investments, focusing on companies within the life sciences, healthcare, and technology sectors. Its investment portfolio includes firms involved in biopharmaceuticals, medical technology, drug delivery technologies, and research instruments. 5AM Ventures is recognized for its commitment to fostering innovation in advanced life science technologies.

Jamil M. Beg

Partner

Brian Daniels

Partner

John D. Diekman

Founding Partner

Max Farina

Associate

Michelle Ho Ph.D

Operating Principal

Peter S. Kim

Venture Advisor

Michael P. Klein

Principal

Pengpeng Li

Associate

Rebecca Lucia

Partner

Vamsi Mootha

Venture Advisor

Deborah Palestrant

Partner

Kush M. Parmar

Managing Partner

Scott M. Rocklage

Founding Partner

Jason Ruth

Principal

Andy J. Schwab

Managing Partner

Katie Bodner Spielberg

Analyst

Lou Tartaglia

Venture Partner

Richard Ulevitch

Venture Partner

Rathnam Venkat

Analyst

Joseph Victor

Venture Advisor

Jonathan Weissman

Venture Advisor

Anna Yaeger

Partner & Head of Public Equities

James W. Young

Venture Partner

Past deals in TMT

TMRW Life Sciences

Series C in 2021
TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology. The company's platform offers an in-clinic robotic storage system and a fully digital chain of custody from clinic to offsite longterm storage, continuous remote and local monitoring and electronically integrated processes characterized by digital health signals received from every oocyte and embryo daily, enabling clients to streamline embryology lab operations, eliminate manual steps and integrates digital quality control.

TMRW Life Sciences

Series B in 2019
TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology. The company's platform offers an in-clinic robotic storage system and a fully digital chain of custody from clinic to offsite longterm storage, continuous remote and local monitoring and electronically integrated processes characterized by digital health signals received from every oocyte and embryo daily, enabling clients to streamline embryology lab operations, eliminate manual steps and integrates digital quality control.

Miikana Therapeutics

Series A in 2004
Miikana Therapeutics is a private held biotechnology company. It is a biopharmaceutical company focuses on the discovery and development of medicines for the treatment of cancer.

Miikana Therapeutics

Series A in 2003
Miikana Therapeutics is a private held biotechnology company. It is a biopharmaceutical company focuses on the discovery and development of medicines for the treatment of cancer.